Clinical Trial

Understanding of Psychotic Disorders in Children With 22q11.2DS

Study acronym: PremiCeS22
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-11-17; most recent amendment 2025-07-29.
Trial Details
NCT Number NCT04639388
Lead Sponsor Hôpital le Vinatier
Conditions 22q11.2 Deletion Syndrome
Enrollment 80 participants
Start Date 2020-11-13
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-30